Protein phosphatase 2a inhibitors for treating myelodysplastic syndromes
US-2017340628-A1 · Nov 30, 2017 · US
Lixte Biotechnology Inc was listed as an assignee on 1 patent publication in 2017.
| Metric | Value |
|---|---|
| Company | Lixte Biotechnology Inc |
| Year | 2017 |
| Patents | 1 |
Representative publications for Lixte Biotechnology Inc in 2017.
Most common classification codes for Lixte Biotechnology Inc in 2017.
| CPC | Patents |
|---|---|
| A61K31/34 | 1 |
| A61K31/454 | 1 |
| A61K31/496 | 1 |
| A61K31/573 | 1 |
| A61K31/706 | 1 |
Navigate to parent entity pages.